ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TESSIE OTERO-TRUITT MD

Endocrinology, Diabetes Metabolism

11,967

$1.15M

653
451 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 46%

$96
Average prescription price

Avg: $137

MICHAEL KOCH MD

Endocrinology, Diabetes Metabolism

9,228

$1.19M

693
544 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 46%

$129
Average prescription price

Avg: $137

DEWEY BAILEY MD

Endocrinology, Diabetes Metabolism

9,078

$1.45M

774
577 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 46%

$159
Average prescription price

Avg: $137

CARL BIVENS MD

Endocrinology, Diabetes Metabolism

7,085

$1.03M

653
443 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 46%

$145
Average prescription price

Avg: $137

BRUCE FARISS M.D>

Endocrinology, Diabetes Metabolism

7,020

$1.11M

680
458 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 46%

$158
Average prescription price

Avg: $137

ROBERT CASTELLUCCI MD

Endocrinology, Diabetes Metabolism

6,600

$852K

666
495 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 46%

$129
Average prescription price

Avg: $137

REKHA NUGARAM M.D.,

Endocrinology, Diabetes Metabolism

6,584

$939K

443
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 46%

$143
Average prescription price

Avg: $137

HATIM MAHMOUD MD

Endocrinology, Diabetes Metabolism

6,243

$686K

460
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 46%

$110
Average prescription price

Avg: $137

MARK MCCLANAHAN M.D.

Endocrinology, Diabetes Metabolism

6,203

$770K

557
453 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 46%

$124
Average prescription price

Avg: $137

JAMES MULINDA MD

Endocrinology, Diabetes Metabolism

5,818

$873K

488
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 46%

$150
Average prescription price

Avg: $137

ALAN KAUPPI MD

Endocrinology, Diabetes Metabolism

5,505

$888K

546
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 46%

$161
Average prescription price

Avg: $137

SCOTT BOERTH M.D.

Endocrinology, Diabetes Metabolism

5,446

$441K

321
264 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 46%

$81
Average prescription price

Avg: $137

MUSTAPHA ABDUL-RAHMAN MD

Endocrinology, Diabetes Metabolism

4,996

$672K

400
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 46%

$134
Average prescription price

Avg: $137

MICHAEL SANTULLI MD

Endocrinology, Diabetes Metabolism

4,809

$514K

293
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 46%

$107
Average prescription price

Avg: $137

FRANCISCO CRUZ MD

Endocrinology, Diabetes Metabolism

4,465

$927K

524
393 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 46%

$208
Average prescription price

Avg: $137

ALLEN BURRIS MD

Endocrinology, Diabetes Metabolism

4,229

$450K

343
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 46%

$106
Average prescription price

Avg: $137

COLETTE MOUSSALLI MD

Endocrinology, Diabetes Metabolism

4,220

$423K

332
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 46%

$100
Average prescription price

Avg: $137

MEREDITH BERGER MD

Endocrinology, Diabetes Metabolism

3,920

$383K

281
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 46%

$98
Average prescription price

Avg: $137

NELLY MAYBEE M.D.

Endocrinology, Diabetes Metabolism

3,850

$697K

361
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 46%

$181
Average prescription price

Avg: $137

GHANDI SAADEH MD

Endocrinology, Diabetes Metabolism

3,770

$555K

404
279 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 46%

$147
Average prescription price

Avg: $137

ANGELA SUTTON MD

Endocrinology, Diabetes Metabolism

3,738

$543K

357
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 46%

$145
Average prescription price

Avg: $137

JOSEPH CHEMPLAVIL M.D.

Endocrinology, Diabetes Metabolism

3,199

$346K

221
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 46%

$108
Average prescription price

Avg: $137

DWIGHT MATTHIAS MD

Endocrinology, Diabetes Metabolism

3,092

$442K

274
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 46%

$143
Average prescription price

Avg: $137

HOWARD HARRISON MD

Endocrinology, Diabetes Metabolism

3,038

$333K

268
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 46%

$109
Average prescription price

Avg: $137

FIROOZEH SHAHIDI MD

Endocrinology, Diabetes Metabolism

2,820

$236K

122
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 46%

$84
Average prescription price

Avg: $137

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank